A study to evaluate the efficacy and safety of Tolvaptan in heart failure patients with peritoneal dialysis
Not Applicable
- Conditions
- End stage renal disease , heart failure
- Registration Number
- JPRN-UMIN000009228
- Lead Sponsor
- Fujisawa City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients who have a history of allergy against tolvaptan or similar compounds 2.anuric patients (urinary output: <100mL/day) 3.patients who cannnot feel thirsty or have difficulty to drink 4.patients whose serum sodium level is over 147mEq/L 5.pregnant or possibly pregnant woman 6. patients who already have taken tolvaptan at randomization 7.patients regarded as inappropriate for this clinical study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method